AACR Annual Meeting 2019: Plenary Examines Global Issues in Cancer
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
Tag: Breast cancer
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
On Friday, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic olaparib (Lynparza) for treating certain...
Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...